International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals; Far-Field Sensing and ...

The placement device for the LivIQ leadless pacemaker. [Image courtesy of Biotronik] Biotronik today announced the initiation ...

Please provide your email address to receive an email when new articles are posted on . Among patients who had transcatheter aortic valve replacement, there was no difference in survival or adverse CV ...

The prospective multi-centre BIO-LivIQ trial will enrol 325 patients across 60 sites worldwide.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among nearly 25,000 Swedish patients who received ...

Around one in every nine patients who undergo TAVI with a new-generation self-expanding device will need permanent pacemaker implantation (PPI) within the next 30 days, according to an analysis of ...

PHOENIX -- The Navitor transcatheter aortic valve replacement (TAVR, TAVI) device was associated with a high pacemaker implantation rate in its pivotal study, but an analysis showed ways to bring that ...

Among Medicare beneficiaries, implantation was especially frequent for female patients and those undergoing tricuspid valve replacement with or without concomitant left-sided heart surgeries.

Background: Patients over the age of 75 represent more than half the recipients of permanent pacemakers. It is not known if they have a different risk of complications than younger patients. Methods: ...

Clinical pacemakers save lives. Implanted in patients’ hearts to keep them beating regularly, the devices are an important part of modern healthcare in the fight against potentially fatal arrhythmias.

An aortic valve calcium score (AVCS) greater than 4510 arbitrary units independently predicts post–transcatheter aortic valve implantation (TAVI) conductive disorders requiring permanent pacemaker ...